These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30698984)

  • 1. Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate.
    Mitachi K; Kurosu SM; Eslamimehr S; Lemieux MR; Ishizaki Y; Clemons WM; Kurosu M
    Org Lett; 2019 Feb; 21(4):876-879. PubMed ID: 30698984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro antitumor activities of novel benzyl urea analogues of sorafenib.
    Lu CS; Tang K; Li Y; Jin B; Yin DL; Ma C; Chen XG; Huang HH
    Yao Xue Xue Bao; 2013 May; 48(5):709-17. PubMed ID: 23888694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of Complex I inhibitor R419 and its derivatives as anticancer agents in HepG2 cells.
    Huang Y; Sun G; Wang P; Shi R; Zhang Y; Wen X; Sun H; Chen C
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2957-2960. PubMed ID: 30001917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship studies of LLY-507 analogues as SMYD2 inhibitors.
    Zhang B; Liao L; Wu F; Zhang F; Sun Z; Chen H; Luo C
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127598. PubMed ID: 33011288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of uridine-5-propylamine derivatives and their use in affinity chromatography of N-acetylglucosaminyltransferases I and II.
    Reck F
    Carbohydr Res; 1995 Oct; 276(2):321-35. PubMed ID: 8542604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety].
    Qin AF; Li Y; Song HR; Chen XG; Jin XF; Wang K; Zhang LJ; Huo LC; Feng ZQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1623-9. PubMed ID: 23460968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
    Hafez HN; El-Gazzar ABA
    Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
    Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
    Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-benzylpiperidinol derivatives as novel USP7 inhibitors: Structure-activity relationships and X-ray crystallographic studies.
    Li M; Liu S; Chen H; Zhou X; Zhou J; Zhou S; Yuan H; Xu QL; Liu J; Cheng K; Sun H; Wang Y; Chen C; Wen X
    Eur J Med Chem; 2020 Aug; 199():112279. PubMed ID: 32497973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2,4-Thiadiazole acyclic nucleoside phosphonates as inhibitors of cysteine dependent enzymes cathepsin K and GSK-3β.
    Pomeislová A; Otmar M; Rubešová P; Benýšek J; Matoušová M; Mertlíková-Kaiserová H; Pohl R; Poštová Slavětínská L; Pomeisl K; Krečmerová M
    Bioorg Med Chem; 2021 Feb; 32():115998. PubMed ID: 33440320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
    Granchi C; Rizzolio F; Palazzolo S; Carmignani S; Macchia M; Saccomanni G; Manera C; Martinelli A; Minutolo F; Tuccinardi T
    J Med Chem; 2016 Nov; 59(22):10299-10314. PubMed ID: 27809504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of diaryl urea derivatives as FLT3 inhibitors.
    Zhang Q; Zhao K; Zhang L; Jiao X; Zhang Y; Tang C
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127525. PubMed ID: 32898697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.
    Xi J; Xu S; Zhang L; Bi X; Ren Y; Liu YC; Gu Y; Xu Y; Lan F; Zha X
    Bioorg Chem; 2018 Aug; 78():7-16. PubMed ID: 29524666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of polyamine-modified uridine and adenosine derivatives--evaluation of DNA binding capacity and cytotoxicity in vitro.
    Ghatnekar J; Hägerlöf M; Oredsson S; Alm K; Elmroth SK; Persson T
    Bioorg Med Chem; 2007 Dec; 15(23):7426-33. PubMed ID: 17869123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based drug discovery by targeting
    Kurosu M
    Future Med Chem; 2019 May; 11(9):927-933. PubMed ID: 30907628
    [No Abstract]   [Full Text] [Related]  

  • 17. A concise diastereoselective approach to enantioenriched substituted piperidines and their in vitro cytotoxicity evaluation.
    Kumaraswamy G; Kumar RS; Sampath B; Poornachandra Y; Ganesh Kumar C; Vemulapalli SPB; Bharatam J
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4439-4443. PubMed ID: 25172418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPAGT1 Inhibitors of Capuramycin Analogues and Their Antimigratory Activities of Solid Tumors.
    Mitachi K; Kansal RG; Hevener KE; Gillman CD; Hussain SM; Yun HG; Miranda-Carboni GA; Glazer ES; Clemons WM; Kurosu M
    J Med Chem; 2020 Oct; 63(19):10855-10878. PubMed ID: 32886511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the structure-activity relationship of the anticancer compound ZJ-101: A role played by the amide moiety.
    Qiu H; Qian S; Head SA; Sanchez PR; Liu JO; Jin Z
    Bioorg Med Chem Lett; 2024 Jun; 105():129741. PubMed ID: 38599296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.
    Li HQ; Yan T; Yang Y; Shi L; Zhou CF; Zhu HL
    Bioorg Med Chem; 2010 Jan; 18(1):305-13. PubMed ID: 19914837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.